Abstract
End-stage heart failure is still associated with a decrease in quality and prognosis of life. Cardiac transplantation remains the final extraordinary therapeutic option for the treatment of truly irreversible end-stage heart failure in all age groups. The selection process of candidates and the acceptance of patients with relative contra-indications is characterized by the experience and skills of an interdisciplinary transplant team, which should have access to different mechanical circulatory support systems for short-term or long-term use: bridging to transplant as well as for recovery. (C) 2000 Lippincott Williams and Wilkins, Inc.
Original language | English (US) |
---|---|
Pages (from-to) | 178-182 |
Number of pages | 5 |
Journal | Current Opinion in Cardiology |
Volume | 15 |
Issue number | 3 |
DOIs | |
State | Published - Jun 13 2000 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine